15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cavum Septi Pellucidi in Symptomatic Former Professional Football Players

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Post-mortem studies reveal a high rate of cavum septi pellucidi (CSP) in chronic traumatic encephalopathy (CTE). It remains, however, to be determined whether or not the presence of CSP may be a potential in vivo imaging marker in populations at high risk to develop CTE. The aim of this study was to evaluate CSP in former professional American football players presenting with cognitive and behavioral symptoms compared with noncontact sports athletes. Seventy-two symptomatic former professional football players (mean age 54.53 years, standard deviation [SD] 7.97) as well as 14 former professional noncontact sports athletes (mean age 57.14 years, SD 7.35) underwent high-resolution structural 3T magnetic resonance imaging. Two raters independently evaluated the CSP, and interrater reliability was calculated. Within National Football League players, an association of CSP measures with cognitive and behavioral functioning was evaluated using a multivariate mixed effects model. The measurements of the two raters were highly correlated (CSP length: rho = 0.98; Intraclass Correlation Coefficient [ICC] 0.99; p < 0.0001; septum length: rho = 0.93; ICC 0.96; p < 0.0001). For presence versus absence of CSP, there was high agreement (Cohen kappa = 0.83, p < 0.0001). A higher rate of CSP, a greater length of CSP, as well as a greater ratio of CSP length to septum length was found in symptomatic former professional football players compared with athlete controls. In addition, a greater length of CSP was associated with decreased performance on a list learning task (Neuropsychological Assessment Battery List A Immediate Recall, p = 0.04) and decreased test scores on a measure of estimate verbal intelligence (Wide Range Achievement Test Fourth Edition Reading Test, p = 0.02). Given the high prevalence of CSP in neuropathologically confirmed CTE in addition to the results of this study, CSP may serve as a potential early in vivo imaging marker to identify those at high risk for CTE. Future research is needed to investigate the pathomechanism underlying the development of CSP after repetitive head impacts, and its potential association with neuropathologically confirmed CTE.

          Related collections

          Author and article information

          Journal
          J Neurotrauma
          J. Neurotrauma
          neu
          Journal of Neurotrauma
          Mary Ann Liebert, Inc. (140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA )
          0897-7151
          1557-9042
          15 February 2016
          : 33
          : 4
          : 346-353
          Affiliations
          [ 1 ]Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital , Harvard Medical School, Boston, Massachusetts.
          [ 2 ]Department of Child and Adolescent Psychiatry, Psychosomatic, and Psychotherapy, Ludwig-Maximilian-University , Munich, Germany.
          [ 3 ]Department of Pediatric Neurology, Dr. von Hauner Children's Hospital, Ludwig-Maximilian-University , Munich, Germany.
          [ 4 ]Department of Biostatistics, Boston University School of Public Health , Boston, Massachusetts.
          [ 5 ]CTE Center, Boston University School of Medicine , Boston, Massachusetts.
          [ 6 ]Alzheimer's Disease Center, Boston University School of Medicine , Boston, Massachusetts.
          [ 7 ]Department of Anatomy and Neurobiology, Boston University School of Medicine , Boston, Massachusetts.
          [ 8 ]Interfaculty Initiative in Health Policy, Harvard University , Cambridge, Massachusetts.
          [ 9 ]Department of Radiology, Brigham and Women's Hospital , Harvard Medical School, Boston, Massachusetts.
          [ 10 ]Center for Clinical Spectroscopy, Department of Radiology, Brigham and Women's Hospital , Harvard Medical School, Boston, Massachusetts.
          [ 11 ]Departments of Neurology and Neurosurgery, Boston University School of Medicine , Boston, Massachusetts.
          [ 12 ] VA Boston Healthcare System , Brockton Division, Brockton, Massachusetts.
          Author notes
          [ * ]

          Equal contribution of first authors.

          [ + ]

          Equal contribution of last authors.

          Address correspondence to: Inga K. Koerte, MD, Psychiatry Neuroimaging Laboratory, Brigham and Women's Hospital 1249 Boylston Street, Boston, MA 02215, E-mail: ikoerte@ 123456bwh.harvard.edu
          Article
          PMC4761807 PMC4761807 4761807 10.1089/neu.2015.3880
          10.1089/neu.2015.3880
          4761807
          26414478
          ae9b86cd-890b-4b8a-ba92-d753d77481c7
          Copyright 2016, Mary Ann Liebert, Inc.
          History
          Page count
          Figures: 4, Tables: 4, References: 39, Pages: 8
          Categories
          Original Articles

          biomarkers,head trauma,MRI,neurodegenerative disorders,traumatic brain injury

          Comments

          Comment on this article